Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Climb Bio Inc.
Headquarters: Wellesley, MA, United States of America
Website: https://climbbio.com/
Year Founded: 2019
Status: Public
Industry Sector: HealthTechnology
CEO: Aoife M. Brennan, MD
Number Of Employees: 9
Enterprise Value: $-33,583,771
PE Ratio: -0.66
Exchange/Ticker 1: NASDAQ:CLYM
Exchange/Ticker 2: N/A
Latest Market Cap: $90,855,000
BioCentury | Feb 25, 2025
Management Tracks
After leaving FDA, Cavazzoni joins Pfizer as CMO
Plus: CFO hires at Nuclera, Crinetics, Terns and updates from Xeris, Inhibikase and Climb Bio
BioCentury | Dec 17, 2024
Finance
Trends in VC funds, obesity start-ups and more: a BioCentury podcast
Plus: Takeaways from the latest
BioCentury | Dec 13, 2024
Product Development
Only the paranoid survive, and the CEO’s paradox, from Aoife Brennan
How CEOs are managing through uncertainty, and why ‘boring’ naked mAbs are the smart move in one field
BioCentury | Nov 13, 2024
Management Tracks
Rubedo names Frederick Beddingfield CEO
Plus: Kian Teik Beh succeeds Frederick Chew at A*STAR, and updates from Climb Bio, DiogenX, Arch, SR One and Koneksa
BioCentury | Oct 4, 2024
Management Tracks
Resolution names Paul Sekhri chair
Plus: Dadswell leaving Illumina as general counsel and updates from Eliem, Codexis, Oculis, Illumina, Eupraxia and PharmaJet
Items per page:
1 - 5 of 5